Back
RAPT Therapeutics Stock Price Chart

This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
40
RAPT
RAPT Therapeutics
Last Price:
$10.60
Seasonality Move:
-6.61%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RAPT is experiencing slight selling pressure.
RAPT Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 8.95 | Buy |
20-day SMA: | 8.45 | Buy |
50-day SMA: | 7.95 | Buy |
200-day SMA: | 10.09 | Buy |
8-day EMA: | 7.86 | Buy |
20-day EMA: | 4.65 | Buy |
50-day EMA: | 2.23 | Buy |
200-day EMA: | 0.61 | Buy |
RAPT Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.62 | Buy |
Relative Strength Index (14 RSI): | 66.01 | Buy |
Chaikin Money Flow: | -24593 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (7.63 - 9.37) | Buy |
Bollinger Bands (100): | (6.93 - 9.63) | Buy |
RAPT Therapeutics Technical Analysis
Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
02 | 03 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for RAPT Therapeutics Stock
Is RAPT Therapeutics Stock a Buy?
-
RAPT Therapeutics share price is 10.52 while RAPT 8-day simple moving average is 8.95, which is a Buy signal.
-
The stock price of RAPT is 10.52 while RAPT Therapeutics 20-day SMA is 8.45, which makes it a Buy.
-
RAPT Therapeutics 50-day simple moving average is 7.95 while RAPT share price is 10.52, making it a Buy technically.
-
RAPT stock price is 10.52 and RAPT Therapeutics 200-day simple moving average is 10.09, creating a Buy signal.
RAPT Technical Analysis vs Fundamental Analysis
Sell
40
RAPT Therapeutics (RAPT)
is a Sell
Is RAPT Therapeutics a Buy or a Sell?
-
RAPT Therapeutics stock is rated a SellThe current RAPT Therapeutics [RAPT] share price is $10.52. The Score for RAPT is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
RAPT Therapeutics Stock Info
Market Cap:
174M
Price in USD:
10.52
Share Volume:
102.1K
RAPT Therapeutics 52-Week Range
52-Week High:
30.08
52-Week Low:
5.67
Sell
40
RAPT Therapeutics (RAPT)
is a Sell
RAPT Therapeutics Share Price Forecast
-
What is the RAPT Therapeutics stock price today?The RAPT Therapeutics stock price is 10.52 USD today.
-
Will RAPT stock go up or go down?RAPT Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is RAPT Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, RAPT Therapeutics is overvalued.
Is RAPT Therapeutics Stock a Buy?
-
RAPT Therapeutics share price is 10.52 while RAPT 8-day exponential moving average is 7.86, which is a Buy signal.
-
The stock price of RAPT is 10.52 while RAPT Therapeutics 20-day EMA is 4.65, which makes it a Buy.
-
RAPT Therapeutics 50-day exponential moving average is 2.23 while RAPT share price is 10.52, making it a Buy technically.
-
RAPT stock price is 10.52 and RAPT Therapeutics 200-day simple moving average is 0.61, creating a Buy signal.
Fundamental Analysis of RAPT Therapeutics
Is RAPT Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $3.99 per share, a decrease next quarter of $0.10 per share, an increase this year of $12.83 per share, and a decrease next year of $0.50 per share.
Technical Analysis of RAPT Therapeutics
Should I short RAPT Therapeutics stock?
-
RAPT Moving Average Covergence Divergence (MACD) indicator is 2.62, suggesting RAPT Therapeutics is a Buy
-
RAPT Therapeutics Relative Strength Index (RSI) is 66.01, which suggest RAPT Therapeutics is overbought
-
The Bollinger Bands (25) for RAPT Therapeutics is (7.63 - 9.37), which suggest RAPT Therapeutics is a Buy
-
The Bollinger Bands (100) for RAPT Therapeutics is (6.93 - 9.63), which suggest RAPT Therapeutics is a Buy
* RAPT Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.